{"id":6238,"date":"2015-07-14T10:12:19","date_gmt":"2015-07-14T10:12:19","guid":{"rendered":"\/?p=6238"},"modified":"2015-07-14T10:39:56","modified_gmt":"2015-07-14T10:39:56","slug":"arch-therapeutics-inc-otcbbarth-regains-some-ground","status":"publish","type":"post","link":"\/articles\/arch-therapeutics-inc-otcbbarth-regains-some-ground\/","title":{"rendered":"Arch Therapeutics Inc. (OTCBB:ARTH) Regains Some Ground"},"content":{"rendered":"\n<p><img loading=\"lazy\" decoding=\"async\" style=\"float: right;\" src=\"\/\/s.hotstocked.com\/hotstocked.com\/repository\/articles\/90\/90707\/fasdfssssss.png\" border=\"0\" width=\"426\" height=\"190\" \/>Arch Therapeutics Inc. (OTCBB:<a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=ARTH\">ARTH<\/a>) investors seemed to be in good spirits on Friday, as the company managed to add 16.67% to its market value in that session without any apparent cause. <\/p>\n<p>Two weeks ago, <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=ARTH\">ARTH<\/a> <\/strong>announced that it intends to raise almost $3.2 million through a private placement made by 19 accredited investors. Five days later, the company&#8217;s filings documented that it had done just that &ndash; and investors were pleased with the development. The process of rising the funds did increase <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=ARTH\">ARTH<\/a>&#8216;s <\/strong>outstanding shares all the way to 92.5 million, but that fact was mostly overlooked because the deal brought a substantial amount of funds in. But was that a oversight?<\/p>\n<p>True, more funds is something <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=ARTH\">ARTH<\/a> <\/strong>desperately needs, as its latest financial report announced that at the end of Q1 2015 it had just:<\/p>\n<ul>\n<li>Cash &#8211; $573 thousand<\/li>\n<li>total current assets &#8211; $606 thousand&nbsp;<\/li>\n<li>total current liabilities &#8211; $1.39 million&nbsp;<\/li>\n<li>No revenues<\/li>\n<li>Net Loss &#8211; $833 thousand<\/li>\n<\/ul>\n<p>Although the figures in the report certainly aren&#8217;t the worst that can be found in the OTC Market&#8217;s pharmaceutical sector, they certainly aren&#8217;t the best, either. However, said numbers aren&#8217;t what&#8217;s really distressing in the report.<\/p>\n<p>The 10-Q stated that between $12 million and $17 million will be needed if <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=ARTH\">ARTH<\/a> <\/strong>want to pursue approval for their products in Europe and the U.S. That money has to come from somewhere, and that source will most probably cause more dilution.<\/p>\n<p>Some simple math shows that it has taken raising a fourth of the capital needed to even try to break through has increased the company&#8217;s shares outstanding by almost 20%.<\/p>\n<p><img decoding=\"async\" style=\"float: left;\" src=\"\/\/s.hotstocked.com\/hotstocked.com\/repository\/articles\/90\/90707\/fasdfas.png\" border=\"0\" \/>Investors would do well to consider that fact and factor the probability of more heavy dilution in their plans before making plans to commit to <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=ARTH\">ARTH<\/a> <\/strong>stock.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Arch Therapeutics Inc. (OTCBB:ARTH) investors seemed to be in good spirits on Friday, as the company managed to add 16.67% to its market value in that session without any apparent cause. Two weeks ago,&#46;&#46;&#46;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[790],"class_list":["post-6238","post","type-post","status-publish","format-standard","hentry","category-news","tag-arth"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/6238","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=6238"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/6238\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=6238"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=6238"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=6238"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}